Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: A prospective study

BACKGROUND: The contraceptive skin patch (CSP) accepted by the U.S. FDA in 2001 includes ethinylestradiol and norelgestromine, whereas the subdermal contraceptive implant (SCI) has etonogestrel and is also approved by the FDA. In Mexico, both are now widely used for contraception but their effects o...

詳細記述

保存先:
書誌詳細
主要な著者: Hernandez-Juarez, Jesus, Garcia-Latorre, Ethel A, Moreno-Hernandez, Manuel, Moran-Perez, Jose Fernando, Rodriguez-Escobedo, Miguel Angel, Cogque-Hernandez, Gerardo, Julián-Nacer, Rubén, Hernandez-Giron, Xochitl, Palafox-Gomez, Rosalia, Isordia-Salas, Irma, Majluf-Cruz, Abraham
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2014
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4044294/
https://ncbi.nlm.nih.gov/pubmed/24767248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-4755-11-33
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料